Company / Shareholders' Equity
SI-BONE, Inc. Shareholders' Equity History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shareholders' Equity
$177.5M
FY2025
5-year range
$98.3M / $177.5M
FY2021-FY2025
Trend
+6.3%
vs FY2024
Sector context
#144 of 166
Health Care
What the data says
SI-BONE, Inc.'s shareholders' equity of $178M is lower than 87% of companies in the Health Care sector (FY2025). Shareholders' Equity has fluctuated over the past 9 years, ranging from -$129M in FY2017 to $178M in FY2025.
Based on SEC 10-K filings.
$178M in FY2025 with a 5-year CAGR of +0.9%.
Improved from $169M to $178M over the past 2 years.
Health Care sector context is included.
Shareholders' Equity over time
Growth rates
- 3-Year CAGR
- +21.8%
- 5-Year CAGR
- +0.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 13% in Health CareTop 87% of 166This company $177.5M Sector average $5.3B
▼
-96.6% below sector average
Key checks
Key Insights
- 5-year CAGR of +0.9%, indicating consistent growth.
- In FY2025, shareholders' equity increased 6.3% year-over-year.
- Ranks #144 out of 166 companies in the Health Care sector.
- Lowest shareholders' equity in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.75 (distress zone, below 1.8 threshold)
- Negative profit margin: -18.5%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shareholders' EquityValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $177.5M | +6.3% |
| FY2024 | $167.0M | -1.4% |
| FY2023 | $169.4M | +72.3% |
| FY2022 | $98.3M | -26.9% |
| FY2021 | $134.4M | -20.6% |
| FY2020 | $169.4M | +168.8% |
| FY2019 | $63.0M | -30.1% |
| FY2018 | $90.2M | +169.7% |
| FY2017 | -$129.4M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026